| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 837 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -837 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -837 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Biotech Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 0 | 47.784 | 46.975 | 46.113 | 45.220 | 41.156 | 40.243 | 40.368 | 40.246 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 1.075 | 1.056 | 1.037 | 1.017 | 0 | 0 | 0 | 0 | - |
| Cash | 0 | 46.709 | 45.919 | 45.076 | 44.203 | 41.156 | 40.243 | 40.368 | 40.246 | - |
| Shareholders Funds | 0 | 35.384 | 34.785 | 34.147 | 33.485 | 30.536 | 29.859 | 29.952 | 29.861 | - |
| Social Capital | 0 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 0 | 12.400 | 12.190 | 11.966 | 11.734 | 10.620 | 10.384 | 10.417 | 10.385 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Biotech Prod S.r.l.